FULC
Fulcrum Therapeutics·NASDAQ
--
--(--)
--
--(--)
4.88 / 10
Netural
Analyst sentiment is skewed bullish with 50% Strong Buy and 25% Buy ratings, though historical win rates vary widely (20% to 100%). Fund-flow metrics are positive (score 7.71/10), with medium-term inflows showing a constructive trend despite negative signals in other buckets. The blend of bullish analyst lean and solid fund inflows offsets some fundamental weaknesses, yet the overall picture remains neutral.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
25%
Hold
0%
Sell
13%
Strong Sell
0%
Date2025-12-08
InstitutionHC Wainwright & Co.
Times predicted3
Historical Win Rate33.3%
What is the market sentiment for FULC?
- FULC holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.88/10 (Netural).
